Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugene A Zhukovsky

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer Research|October 3, 2008
Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemiaHolly M Horton, Matthew J Bernett, Erik Pong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid LeukemiaUwe Reusch, Kimberly H Harrington, Chelsea J Gudgeon, et al.
Mabs|January 30, 2025
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidityJeremy Loyau, Thierry Monney, Marco Montefiori, et al.
Frontiers in Immunology|May 8, 2023
Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancerEmilia Rabia, Véronique Garambois, Christine Dhommée, et al.
Nature Cancer|September 11, 2024
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cellsLaura Carretero-Iglesia, Olivia J Hall, Jérémy Berret, et al.
Science (New York, N.Y.)|September 27, 2003
Inactivation of TNF signaling by rationally designed dominant-negative TNF variantsPaul M Steed, Malú G Tansey, Jonathan Zalevsky, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer Research|October 3, 2008
Potent in vitro and in vivo activity of an Fc-engineered anti-CD19 monoclonal antibody against lymphoma and leukemiaHolly M Horton, Matthew J Bernett, Erik Pong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2016
Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid LeukemiaUwe Reusch, Kimberly H Harrington, Chelsea J Gudgeon, et al.
Mabs|January 30, 2025
Biparatopic binding of ISB 1442 to CD38 in trans enables increased cell antibody density and increased avidityJeremy Loyau, Thierry Monney, Marco Montefiori, et al.
Frontiers in Immunology|May 8, 2023
Design and selection of optimal ErbB-targeting bispecific antibodies in pancreatic cancerEmilia Rabia, Véronique Garambois, Christine Dhommée, et al.
Nature Cancer|September 11, 2024
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cellsLaura Carretero-Iglesia, Olivia J Hall, Jérémy Berret, et al.
Science (New York, N.Y.)|September 27, 2003
Inactivation of TNF signaling by rationally designed dominant-negative TNF variantsPaul M Steed, Malú G Tansey, Jonathan Zalevsky, et al.
Pageof 2